
PRVA Stock Forecast & Price Target
PRVA Analyst Ratings
Bulls say
Privia Health Group Inc has shown strong execution in value-based care partnerships, evidenced by a 20% year-over-year increase in MSSP beneficiaries following a $25 million acquisition in February 2023, alongside a notable improvement in savings rates by 150 basis points. The company has successfully integrated over 100 providers into its platform, highlighting its operational capabilities and commitment to enhancing physician practices. Additionally, while Privia is focused on expanding through large health systems, the potential for organic growth among individual physicians will be crucial in achieving its long-term growth targets.
Bears say
Privia Health Group Inc. faces a challenging outlook due to anticipated declines in Medicaid enrollment, as indicated by the guidance from its Medicaid operating partners. The company expects an 8%-10% decrease in Medicaid membership on a same-store basis by the end of the year, stemming from re-determination activities following the conclusion of the public health emergency. This expected decline could adversely affect Privia's revenue and overall financial performance, raising concerns about its future growth prospects.
This aggregate rating is based on analysts' research of Privia Health Group and is not a guaranteed prediction by Public.com or investment advice.
PRVA Analyst Forecast & Price Prediction
Start investing in PRVA
Order type
Buy in
Order amount
Est. shares
0 shares